EnPlusOne Biosciences to Attend and Present Poster at OTS Annual Meeting
EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today announced that Daniel Wiegand, CEO, and Jonathan Rittichier, CSO, both co-founders of the company, will be participating in the 19th annual meeting of the Oligonucleotide Therapeutics Society (OTS) in Barcelona, Spain, beginning October 22nd. The company, which is a bronze level sponsor of the annual meeting, will also be delivering a poster presentation that highlights recent technical developments on its propriety enzymatic RNA oligonucleotide synthesis technology.